87 -4 (28/2) 2019 — Farmonculova Y., Juraeva Kh. — OPTIMIZATION OF THE TACTICS OF MANAGEMENT OF NEWBORN CHILDREN WITH LASTING HYPERBILIRUBINEMIA

OPTIMIZATION OF THE TACTICS OF MANAGEMENT OF NEWBORN CHILDREN WITH LASTING HYPERBILIRUBINEMIA

Farmonculova Y., Andijan State Medical Institute.

Juraeva Kh. Andijan State Medical Institute.

Resume,

Hyperbilirubinemia of the newborn is a common clinical problem that occurs in the neonatal period, especially in the first week of life. Nearly 27% of newborns develop hyperbilirubinemia. According to the National Neonatal- Perinatal Database (NNPD), the incidence of hyperbilirubinemia in newborns in maternity hospitals is 33%, which is a cause for concern for neonatologists and parents of sick children. Hyperbilirubinemia of newborns is dangerous for the development of nuclear jaundice (hyperbilirubin encephalopathy), because unconjugated bilirubin freely passes through the blood-brain barrier, leading to the destruction of nerve cells, which leads to the development of neurological disorders in the newborn and form irreversible complications in the form of infantile paralysis. Therefore, the timely detection and treatment of neonatal hyperbilirubinemia is very important, and requires careful monitoring and appropriate preparation.

Key words: hyperbilirubinemia, newborn, childhood, neonatal period.

First page

324

Last page

327

For citation: Farmonculova Y., Juraeva Kh.Optimization of the tactics of management of newborn children with lasting hyperbilirubinemia//New Day in Medicine 4(28)2019 324-327 https://cutt.ly/BbhKFKj

List of References

1. Абдуллаева М.Э., Тимбаев О.С. Оценка степени зрелости до­ношенных новорожденных // Педиатрия. 2002; 5: 106-108.
2. Аверьянова H.H., Морозова Я.С, Никитина И.Л., Швабский O.P. Характеристика периода адаптации при раннем прикла­дывании новорожденного к груди // Материалы Вторых Пи- чугинских чтений. г. Пермь, 2002; 165-168.
3. Васильева O.A., Картелишев АВ, Румянцев АП: Месхи Н.Т. Фармаколазерная профилактика перинатальных осложнения хронической: фетоплацентарной недостаточностью // Педи­атрия: – 2007. -т.86. -№1. -С. 119-126.
4. Воронкова И.Ф., Маковицкая Г.А. Функциональное состояние. печени у новорожденных с конъюгационной гипербили­рубинемией // Педиатрия: -2002. №1. – С.30-32.
5. Дуплягина. Н.П., Олехнович В.М., Бовина Т.В., Мамаев H.H., Пацинская H.A. Неблагоприятные события в виде геморраги­ческого синдрома. у детей; вакцинированных против гепатита В // Материалы IV конгресса педиатров России: 2007; 223.
6. Казакова; JI.M. y Шабалдин A.B., Глушков АН., Корзунина В: В. Диагностика, внутриутробных инфекций у новорожден­ных // Педиатрия. 1999; 5: 26-31.
7. Goldberg D.M., Martin J.V. Role of gamma-glutamyl transpeptidase activity in the diagnosis of hepatobiliary disease / / Digestion. 1975; 1(12): 232-246.
8. Yetman R.J., Parks D.K., Huseby V., Mistry K., Garcia J. Rebound bilirubin levels in infants receiving phototherapy. // Pediatr. 1998; 133: 705-717.
9. Yeung C.Y., Tarn L.S., Chan A Phenobarbitone prophylaxis forneonatal hyperbilirubinemia // Pediatrics. 1971; 48(3): 372-376.
10. Halamek L.P., Stevenson D.K. Neonatal jaundice and liver disease. Neonatal-perinatal medicine: diseases of the fetus and infant / / St. Louis: Mosby-Year Book. 1997; 2: 1345-1389.